Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Osteoarthritis Knee Pain

In brief

A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.

Key facts

Study ID
NCT07226258
Run by
Saol Therapeutics Inc
People needed
150
Starts
2025-11-07
Expected to finish
2027-02-28
Last updated by the study team
2026-07-21

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.